Skip to main content
OpenTrials

Clinical trial condition

Plaque Psoriasis

Explore clinical trials studying Plaque Psoriasis. Study availability and eligibility vary by location and protocol.

298 public trials 24 recruiting studies
Refine in advanced search Browse all conditions

Plaque Psoriasis trial results

Active, not recruiting

A Study of JNJ-77242113 for the Treatment of Participants With Moderate to Severe Plaque Psoriasis

NCT06143878

Conditions
Plaque Psoriasis
Locations
  • Medical Dermatology Specialists Phoenix, Arizona, United States
  • Center for Dermatology and Plastic Surgery Scottsdale, Arizona, United States
  • Johnson Dermatology Fort Smith, Arkansas, United States
  • First OC Dermatology Fountain Valley, California, United States
View all 164 locations
View Trial Details
Active, not recruiting

A Study of JNJ-77242113 for the Treatment of Participants With Moderate to Severe Plaque Psoriasis (ICONIC-ADVANCE 2)

NCT06220604

Conditions
Plaque Psoriasis
Locations
  • Alliance Dermatology and MOHS Center P C Phoenix, Arizona, United States
  • California Dermatology & Clinical Research Institute Encinitas, California, United States
  • T Joseph Raoof Md Inc Encino, California, United States
  • UCSF Fresno Fresno, California, United States
View all 128 locations
View Trial Details
Active, not recruiting

A Study of JNJ-77242113 in Adolescent and Adult Participants With Moderate to Severe Plaque Psoriasis

NCT06095115

Conditions
Plaque Psoriasis
Locations
  • Medical Dermatology Specialists Phoenix, Arizona, United States
  • Johnson Dermatology Fort Smith, Arkansas, United States
  • First OC Dermatology Fountain Valley, California, United States
  • Center for Dermatology Clinical Research Fremont, California, United States
View all 170 locations
View Trial Details
Active, not recruiting

Dose Ranging Study of ORKA-001 in Patients With Moderate-to-Severe Plaque Psoriasis

NCT07290569

Conditions
Plaque Psoriasis
Locations
  • Oruka Therapeutics Investigative Site Phoenix, Arizona, United States
  • Oruka Therapeutics Investigative Site North Little Rock, Arkansas, United States
  • Oruka Therapeutics Investigative Site Los Angeles, California, United States
  • Oruka Therapeutics Investigative Site Los Angeles, California, United States
View all 36 locations
View Trial Details
Active, not recruiting

Open-Label Extension Study to Evaluate the Long Term Safety and Efficacy of ESK-001 in Plaque Psoriasis

NCT05739435

Conditions
Plaque Psoriasis
Locations
  • Investigator Site # 1029 Birmingham, Alabama, United States
  • Investigator Site #1001 Phoenix, Arizona, United States
  • Investigator Site # 1023 Rogers, Arkansas, United States
  • Investigator Site #1021 Encinitas, California, United States
View all 38 locations
View Trial Details
Active, not recruiting

A Study to Assess the Efficacy and Safety of Apremilast in Japanese Pediatric Participants With Moderate to Severe Plaque Psoriasis

NCT05565560

Conditions
Plaque Psoriasis
Locations
  • Nagoya City University Hospital Nagoya, Aichi-ken, Japan
  • Fukuoka University Hospital Fukuoka, Japan
  • Hospital of the University of Occupational and Environmental Health, Japan Kitakyushu-shi, Fukuoka, Japan
  • Kurume University Hospital Kurume-shi, Fukuoka, Japan
View all 29 locations
View Trial Details
Active, not recruiting

ORKA-001 Versus Placebo in Patients With Moderate-to-Severe Plaque Psoriasis

NCT07090330

Conditions
Plaque Psoriasis
Locations
  • Oruka Therapeutics Investigative Site Fountain Valley, California, United States
  • Oruka Therapeutics Investigative Site Los Angeles, California, United States
  • Oruka Therapeutics Investigative Site San Diego, California, United States
  • Oruka Therapeutics Investigative Site Santa Ana, California, United States
View all 26 locations
View Trial Details
Active, not recruiting

A Study of TAK-279 in Participants With Moderate-to-Severe Plaque Psoriasis

NCT06550076

Conditions
Plaque Psoriasis
Locations
  • Total Dermatology Birmingham, Alabama, United States
  • University of Alabama Hospital - Whitaker Clinic - Birmingham, Alabama, United States
  • Cahaba Dermatology Skin Health Center Hoover, Alabama, United States
  • Medical Dermatology Specialists Phoenix, Arizona, United States
View all 278 locations
View Trial Details

Related conditions